Arrowhead Pharmaceuticals Financial Overview
Arrowhead Pharmaceuticals's market cap is currently $9.35B. The company's EPS TTM is $-0.11; its P/E ratio is ―; Arrowhead Pharmaceuticals is scheduled to report earnings on November 25, 2025, and the estimated EPS forecast is $0.12. See an overview of income statement, balance sheet, and cash flow financials.
